BRAF and melanoma: As previously discussed, numerous combinations of BRAF/MEK inhibitors such as dabrafenib/trametinib and vemurafenib/cobimetinib, have proven to be more effective than BRAF inhibitors alone in treating BRAF V600 mutant melanoma [70].